Recent Advances in Radiofrequency Ablation for the Management of Hepatocellular Carcinoma
Hepatitis Monthly: October 10, 2012,
12 (10); 5945
October 10, 2012
Article Type: Review Article
July 31, 2011
January 9, 2012
T. Recent Advances in Radiofrequency Ablation for the Management of Hepatocellular Carcinoma,
Hepatocellular carcinoma (HCC) is one of the most common malignant diseases in the world. Because less than 20% of patients with HCC are resectable, various types of non-surgical treatment have been developed.
At present, radiofrequency ablation (RFA) is accepted as the standard local treatment for patients with HCC because of its superior local control and overall survival compared to other local treatments.
New devices for RFA and combination treatments of RFA with other procedures have been developed to improve anti-tumoral effects.
This review mainly focuses on the status of RFA in the management of HCC and recent advances in RFA treatment technology.
Carcinoma, Hepatocellular; Treatment; Catheter Ablation
© 2012, Hepatitis Monthly. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.